 In the first part of this article, I provide easy-to-digest overviews of U.S. pharmaceutical and medical technology giant Johnson Johnson and Swiss biologics and diagnostics king Roche Holding AG. I will explain which of the two companies is the better choice if you think long-term and focus on dividends that are expected to be used to cover living expenses. 